BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8328577)

  • 1. Sertraline and mental retardation with obsessive-compulsive disorder.
    Wiener K; Lamberti JS
    Am J Psychiatry; 1993 Aug; 150(8):1270. PubMed ID: 8328577
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    Dodt JE; Byerly MJ; Cuadros C; Christensen RC
    Am J Psychiatry; 1997 Apr; 154(4):582. PubMed ID: 9090357
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    Allen L; Tejera C
    Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
    [No Abstract]   [Full Text] [Related]  

  • 4. Panic attacks precipitated by sertraline.
    Zinner SH
    Am J Psychiatry; 1994 Jan; 151(1):147-8. PubMed ID: 8267115
    [No Abstract]   [Full Text] [Related]  

  • 5. Sertraline in the treatment of neurotic excoriations and related disorders.
    Kalivas J; Kalivas L; Gilman D; Hayden CT
    Arch Dermatol; 1996 May; 132(5):589-90. PubMed ID: 8624163
    [No Abstract]   [Full Text] [Related]  

  • 6. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Koran LM; Mueller K; Maloney A
    J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication optimization during clozapine treatment.
    Suppes T; Rush AJ
    J Clin Psychiatry; 1996 Jul; 57(7):307-8. PubMed ID: 8666574
    [No Abstract]   [Full Text] [Related]  

  • 9. Inability to cry during SRI treatment.
    Oleshansky MA; Labbate LA
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract]   [Full Text] [Related]  

  • 10. Sertraline treatment of aggression in a developmentally disabled patient.
    Campbell JJ; Duffy JD
    J Clin Psychiatry; 1995 Mar; 56(3):123-4. PubMed ID: 7883733
    [No Abstract]   [Full Text] [Related]  

  • 11. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    Byerly MJ; Goodman WK; Christensen R
    Am J Psychiatry; 1996 Sep; 153(9):1232-3. PubMed ID: 8780435
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin reuptake blockers for the treatment of obsessional jealousy.
    Stein DJ; Hollander E; Josephson SC
    J Clin Psychiatry; 1994 Jan; 55(1):30-3. PubMed ID: 8294389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P; Mardomingo Sanz MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors in OCD.
    Montgomery SA; Bullock T; Fineberg N; Montgomery D
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():255A-256A. PubMed ID: 1498831
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract]   [Full Text] [Related]  

  • 19. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D; McTavish D
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Greist J; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowitz M; Lydiard RB; Rasmussen S; White K
    Arch Gen Psychiatry; 1995 Apr; 52(4):289-95. PubMed ID: 7702445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.